In this respect, previous studies investigated the role of NLRP3 inflammasome in several experimental models of colitis, highlighting remarkable beneficial effects as a results of its pharmacological modulation (Pellegrini et al., 2017b). This evidence concerns the gene NLRP3 and colitis.